作为药剂师的支持工具的GPT-4的潜力:使用日本国家药剂师考试的分析研究
1Department of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Shiga, Japan.
JMIR medical education
|October 14, 2023
概括
人工智能 (AI) 聊天机器人GPT-4在回答日本国家药剂师考试问题方面显示出潜力,达到60%以上的准确性. 需要进一步的评估,以解决药房实践的专业化和基于计算的查询的局限性.
科学领域:
- 药房 药房 药房 药房
- 人工智能的人工智能
- 医疗信息学 医疗信息学
背景情况:
- 人工智能 (AI) 和机器学习越来越多地应用于医疗保健.
- 像GPT-4这样的AI聊天机器人在支持医疗保健专业人员提供医疗信息和教育方面表现有前途.
- 先进的人工智能模型在药房实践中的实用性在很大程度上仍未被探索.
研究的目的:
- 评估GPT-4在日本国家药剂师考试 (JNEP) 的表现.
- 评估GPT-4作为药剂师在日常实践中的支持工具的潜力.
主要方法:
- GPT-4处理了第107和108届JNEP的问题.
- 需要图形解释的问题被排除在外.
- 计算了准确率,并与考试合格标准进行了比较.
主要成果:
- GPT-4的整体准确率为64.5% (第107届JNEP) 和62.9% (第108届JNEP).
- 除了基于图表的问题外,准确性分别提高到78.2%和75.3%.
- 对于物理,化学和基于计算的问题,观察到的准确性较低.
结论:
- GPT-4展示了支持药剂师的潜力,但在基于专业,计算和图表的问题上存在局限性.
- 需要进一步的研究来评估GPT-4在现实世界临床环境中的适用性.
- 解决目前的局限性可能会提高GPT-4作为药剂师工具的可靠性.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
192
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
192
Drug Administration and Therapy Phases: Overview
489
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
489
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Analysis of Population Pharmacokinetic Data
268
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
268
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Nonlinear Pharmacokinetics: Role of Transporters
55
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
55


